Romano J H, Nagasubramanian S, Poinoosawmy D
Br J Ophthalmol. 1981 Jan;65(1):50-2. doi: 10.1136/bjo.65.1.50.
A trial of the efficacy of low-concentration nonmiotic therapy was carried out, the aim being to minimise the side effects produced by 1% adrenaline or pilocarpine. A total of 77 eyes with open-angle glaucoma were studied in both parts of the trial. Thirty-nine eyes had a base-line pressure of over 28 mmHg and 28 eyes a pressure of 30 mmHg or over. In the comparison between Ganda 1.02 and adrenaline 1% (Simplene) the mean lowering of intraocular pressure was 8.6 mmHg with Ganda and 7.69 mmHg with Simplene. In the comparison between Ganda 1.02 and pilocarpine 1% (Sno-Pilo) the mean decrease was 6.34 mmHg with Ganda and 6.13 mmHg with Sno-Pilo. The resulting falls in intraocular pressure were highly significant statistically, but the differences between the effects of the 3 drugs were not significant. No significant side effects were reported with Ganda 1.02, and in particular no ptosis or superficial punctate staining of the cornea was noted.
进行了一项低浓度非缩瞳疗法疗效的试验,目的是尽量减少1%肾上腺素或毛果芸香碱产生的副作用。试验的两个部分共研究了77只开角型青光眼眼。39只眼基线眼压超过28 mmHg,28只眼眼压为30 mmHg或更高。在甘达1.02与1%肾上腺素(Simplene)的比较中,甘达使眼压平均降低8.6 mmHg,Simplene使眼压平均降低7.69 mmHg。在甘达1.02与1%毛果芸香碱(Sno-Pilo)的比较中,甘达使眼压平均降低6.34 mmHg,Sno-Pilo使眼压平均降低6.13 mmHg。眼压下降在统计学上具有高度显著性,但这三种药物效果之间的差异不显著。未报告甘达1.02有显著副作用,尤其未发现上睑下垂或角膜浅层点状染色。